Abstract / Summary
Aim. To assess lung function in coal miners with occupational chronic obstructive pulmonary disease (COPD) of different severity and to evaluate the associations between spirometric parameters and six-minute walk distance (6MWD). Materials and methods. This single-center cross-sectional study included 83 male coal miners with occupational COPD (mean age 54.6 ± 7.4 years [mean ± SD]; mean occupational exposure duration 25.7 ± 7.8 years [mean ± SD]). COPD was confirmed by persistent post-bronchodilator airflow limitation (FEV1/FVC < 0.70), and its occupational origin was established by an occupational pathology commission. Post-bronchodilator spirometry included FVC, FEV1, FEV1/FVC, MEF25, MEF50, MEF75, and FEF25–75. Expiratory flow parameters were analyzed as continuous variables. Exercise capacity was assessed using the six-minute walk test (6MWT). Associations between lung function parameters and 6MWD were evaluated using Pearson correlation analysis. Results. Patients with GOLD III–IV had a shorter 6MWD than those with GOLD I–II (364.1 ± 58.2 vs. 462.4 ± 64.7 m; p = 2.17 × 10−10) and a greater decrease in SpO2 from baseline to the value recorded immediately after the test (−4.7 ± 1.8% vs. −1.9 ± 1.2%; p = 3.43 × 10−12). 6MWD was positively correlated with FEV1 (r = 0.44; p = 0.000032), FVC (r = 0.39; p = 0.000268), MEF25 (r = 0.41; p = 0.000118), MEF50 (r = 0.43; p = 0.000050), MEF75 (r = 0.48; p = 0.000004), and FEF25–75 (r = 0.46; p = 0.000012). Conclusions. In coal miners with occupational COPD, greater airflow limitation was associated with lower exercise capacity and a greater fall in SpO2 measured immediately after the 6MWT. Additional expiratory flow parameters were associated with 6MWD; however, this cross-sectional correlation analysis does not establish their independent or incremental value beyond FEV1. A comprehensive functional assessment combining conventional spirometry, additional expiratory flow parameters, and the 6MWT may therefore be useful for describing functional impairment in occupational COPD.